» Articles » PMID: 21874003

Germline Mutations in BAP1 Predispose to Melanocytic Tumors

Abstract

Common acquired melanocytic nevi are benign neoplasms that are composed of small, uniform melanocytes and are typically present as flat or slightly elevated pigmented lesions on the skin. We describe two families with a new autosomal dominant syndrome characterized by multiple, skin-colored, elevated melanocytic tumors. In contrast to common acquired nevi, the melanocytic neoplasms in affected family members ranged histopathologically from epithelioid nevi to atypical melanocytic proliferations that showed overlapping features with melanoma. Some affected individuals developed uveal or cutaneous melanomas. Segregating with this phenotype, we found inactivating germline mutations of BAP1, which encodes a ubiquitin carboxy-terminal hydrolase. The majority of melanocytic neoplasms lost the remaining wild-type allele of BAP1 by various somatic alterations. In addition, we found BAP1 mutations in a subset of sporadic melanocytic neoplasms showing histological similarities to the familial tumors. These findings suggest that loss of BAP1 is associated with a clinically and morphologically distinct type of melanocytic neoplasm.

Citing Articles

An epigenetic pathway regulates MHC-II expression and function in B cell lymphoma models.

Zhang T, Beytullahoglu O, Tulaiha R, Luvisotto A, Szczepanski A, Tsuboyama N J Clin Invest. 2025; 135(2.

PMID: 39817454 PMC: 11735100. DOI: 10.1172/JCI179703.


Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.

George T, Lee J, DeRemer D, Hosein P, Staal S, Markham M JCO Precis Oncol. 2024; 8:e2400406.

PMID: 39626160 PMC: 11616782. DOI: 10.1200/PO-24-00406.


[Dermoscopy of melanocytoma-groundbreaking or established knowledge].

Kranke T, Blum A Dermatologie (Heidelb). 2024; 75(12):972-975.

PMID: 39433580 PMC: 11614974. DOI: 10.1007/s00105-024-05423-7.


Extraction and Prioritization of a Gene-Cancer-By-Survival Network Involved in Homeostasis of Intracellular Calcium Concentrations Using TCGA PANCAN Data.

Tombaz M, Yanyatan C, Keskus A, Konu O Bioelectricity. 2024; 4(2):92-102.

PMID: 39350776 PMC: 11441359. DOI: 10.1089/bioe.2022.0013.


BRCA1-associated-protein-1 inactivated melanocytic tumours: characterisation of the clinicopathological spectrum and immunohistochemical expression pattern of preferentially expressed antigen in melanoma.

Xu Y, Gru A, Brenn T, Wiedemeyer K Histopathology. 2024; 86(2):294-301.

PMID: 39268598 PMC: 11649512. DOI: 10.1111/his.15318.


References
1.
Stokes M, Rush J, MacNeill J, Min Ren J, Sprott K, Nardone J . Profiling of UV-induced ATM/ATR signaling pathways. Proc Natl Acad Sci U S A. 2007; 104(50):19855-60. PMC: 2148387. DOI: 10.1073/pnas.0707579104. View

2.
Van Raamsdonk C, Griewank K, Crosby M, Garrido M, Vemula S, Wiesner T . Mutations in GNA11 in uveal melanoma. N Engl J Med. 2010; 363(23):2191-9. PMC: 3107972. DOI: 10.1056/NEJMoa1000584. View

3.
Jensen D, Proctor M, Marquis S, Gardner H, Ha S, Chodosh L . BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene. 1998; 16(9):1097-112. DOI: 10.1038/sj.onc.1201861. View

4.
Palmedo G, Hantschke M, Rutten A, Mentzel T, Hugel H, Flaig M . The T1796A mutation of the BRAF gene is absent in Spitz nevi. J Cutan Pathol. 2004; 31(3):266-70. DOI: 10.1111/j.0303-6987.2003.00179.x. View

5.
Van Raamsdonk C, Bezrookove V, Green G, Bauer J, Gaugler L, OBrien J . Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2008; 457(7229):599-602. PMC: 2696133. DOI: 10.1038/nature07586. View